| Identification | Back Directory | [Name]
adenosine N1-oxide | [CAS]
146-92-9 | [Synonyms]
ANO 1-Oxoadenosine Adenosine 1-oxide adenosine N1-oxide adenosine N(sup 1)-oxide 1-Oxylatoadenosine-1-ium Adenosine N1-Oxide, ANO 6-AMINO-9-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]PURIN-7-IUM-7-OLATE Adenosine N1-Oxide ANO, natural occurring nucleoside,Antiviral and anti-inflammatory agent | [EINECS(EC#)]
205-683-0 | [Molecular Formula]
C10H13N5O5 | [MDL Number]
MFCD00037993 | [MOL File]
146-92-9.mol | [Molecular Weight]
283.24 |
| Hazard Information | Back Directory | [Uses]
Adenosine N1-oxide is an oral active anti-inflammatory agent, and can be isolated from royal jelly. Adenosine N1-oxide promotes osteogenic and adipocyte differentiation[1][2]. | [in vivo]
Adenosine N1-oxide (oral administration, 135 mg/kg for three times) reduces the lethality caused by LPS (HY-D1056)-induced endotoxin shock in BALB/c mice[1]. | Animal Model: | LPS-induced endotoxin shock in BALB/c mice[1] | | Dosage: | 135 mg/kg for three times | | Administration: | Oral administration | | Result: | Reduced the lethality caused by LPS (HY-D1056)-induced endotoxin shock in BALB/c mice. |
| [References]
[1] Kohno K, et al. Anti-inflammatory effects of adenosine N1-oxide. J Inflamm (Lond). 2015;12(1):2. Published 2015 Jan 20. DOI:10.1186/s12950-014-0045-0 [2] Ohashi E, et al. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation. Biol Pharm Bull. 2019;42(6):968-976. DOI:10.1248/bpb.b18-00988 |
|
|